<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164839">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01946997</url>
  </required_header>
  <id_info>
    <org_study_id>03-11-05-03</org_study_id>
    <nct_id>NCT01946997</nct_id>
  </id_info>
  <brief_title>Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography</brief_title>
  <official_title>Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Quan Dong Nguyen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate topographic features of the posterior pole of the
      eye in normal subjects as well as in subjects with diabetes mellitus but without diabetic
      retinopathy (DR) using optical coherence tomography (OCT).  The investigators proposal is a
      novel study to determine retinal volume of normal and diabetic subjects without DR.
      Specifically, the investigators will establish a standardized reference range for retinal
      thickness and volume that will provide standards for OCT analysis of different clinical
      trials for retinal diseases.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Normative retinal thickness data for comparison</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Normative retinal thickness data for comparison</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Group 1: Non Diabetic</arm_group_label>
    <description>Normal retina</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Diabetes with no retinopathy</arm_group_label>
    <description>Diabetic patients without diabetic retinopathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OCT Imaging both Normal and diabetic groups</intervention_name>
    <description>Images taken to determine thickness values in the retina</description>
    <arm_group_label>Group 1: Non Diabetic</arm_group_label>
    <arm_group_label>Group 2: Diabetes with no retinopathy</arm_group_label>
    <other_name>Ocular Coherence tomography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Normal, non-diabetic patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy retinas

          -  Willingness to sign informed consent to have OCT images taken.

        Exclusion Criteria:

          -  No macular pathology

          -  No Diabetes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quan D Nguyen, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 19, 2013</lastchanged_date>
  <firstreceived_date>September 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Quan Dong Nguyen</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
